| Stage | CPRT | % of rev | GGG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $586M | 100.00% | CPRT ×1.97 |
| Gross profit | $988M | 85.75% | $296M | 50.52% | CPRT +35.2pp |
| Operating income | $369M | 32.01% | $148M | 25.26% | CPRT +6.8pp |
| Pre-tax income | $405M | 35.12% | $152M | 25.99% | CPRT +9.1pp |
| Net income | $327M | 28.36% | $122M | 20.73% | CPRT +7.6pp |
| Stage | CPRT | GGG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $586M100.00% | CPRT ×1.97 |
| Gross profit | 85.75%$988M | 50.52%$296M | CPRT +35.2pp |
| Operating income | 32.01%$369M | 25.26%$148M | CPRT +6.8pp |
| Pre-tax income | 35.12%$405M | 25.99%$152M | CPRT +9.1pp |
| Net income |
| 28.36%$327M |
| 20.73%$122M |
| CPRT +7.6pp |
No disclosed counterparties: GGG.
None